Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2014; 20(22): 6968-6973
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6968
Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma
Gen Sugiyama, Yoshinobu Okabe, Yusuke Ishida, Fumihiko Saitou, Ryuichi Kawahara, Hiroto Ishikawa, Hiroyuki Horiuchi, Hisafumi Kinoshita, Osamu Tsuruta, Michio Sata
Gen Sugiyama, Yoshinobu Okabe, Yusuke Ishida, Fumihiko Saitou, Ryuichi Kawahara, Hiroto Ishikawa, Hiroyuki Horiuchi, Hisafumi Kinoshita, Osamu Tsuruta, Michio Sata, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan
Author contributions: Sugiyama G, Okabe Y and Ishida Y performed endoscopic treatment; Sugiyama G and Saitou F contributed to conception, design, and acquisition of data; Kawahara R, Ishikawa H, Horiuchi H and Kinoshita H performed surgery; Tsuruta O and Sata M were in charge of this study.
Correspondence to: Yoshinobu Okabe, MD, PhD, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. okabe_yoshinobu@kurume-u.ac.jp
Telephone: +81-942-353311 Fax: +81-942-342623
Received: September 22, 2013
Revised: January 6, 2014
Accepted: February 17, 2014
Published online: June 14, 2014
Core Tip

Core tip: Taking into account quality of life, percutaneous transhepatic biliary drainage is normally carried out as a first choice endoscopic biliary stenting in recent years. The resulting prolonged survival time was observed as significantly different when the non-successful group was compared to the successful group. Obstructive jaundice caused by hepatocellular carcinoma is a complex disease state; therefore endoscopic biliary stenting should be investigated from a different viewpoint from that of biliary drainage performed for other malignant biliary obstructions, such as bile duct carcinoma.